Lonza Group (OTCMKTS:LZAGY) Shares Gap Up – Should You Buy?

Lonza Group Ag (OTCMKTS:LZAGY)’s share price gapped up before the market opened on Tuesday . The stock had previously closed at $61.20, but opened at $63.64. Lonza Group shares last traded at $63.85, with a volume of 1,000 shares traded.

Analyst Ratings Changes

Separately, Zacks Research upgraded Lonza Group from a “strong sell” rating to a “hold” rating in a research report on Wednesday, April 8th. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy”.

Lonza Group Price Performance

The company’s fifty day moving average price is $62.87 and its two-hundred day moving average price is $65.25. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.77 and a current ratio of 2.24.

Lonza Group Company Profile

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.